Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 3.

Change of Body Mass Index and Lipid Profile Among Propensity Score-matched Helicobacter pylori Eradicated and non-Helicobacter pylori Eradicated Patients

Characteristics HPE (n = 131) Within-group
P-value		 Non-HPE (n = 131) Within-group
P-value		 Between-group
P-value
BMI (kg/m2)
Initial 24.49 (2.79) 24.39 (3.32) 0.174 (T)
Follow-up 24.66 (2.93) 24.50 (3.63)
Change 0.72 (4.27) 0.022 (S) 0.42 (5.08) 0.083 (S) 0.921 (W)
Hemoglobin (g/dL), mean
Initial 14.37 (4.06) 14.35 (1.61) 0.983 (T)
Follow-up 14.12 (1.50) 14.27 (1.56)
Change 0.16 (9.87) 0.784 (S) –0.16 (5.98) 0.695 (S) 0.599 (W)
C-reactive protein (mg/dL)
Initial 0.32 (0.52) 0.17 (0.35) 0.307 (T)
Follow-up 0.44 (0.92) 0.27 (0.66)
Change 2.90 (63.57) 0.877 (P) 81.33 (201.78) 0.418 (P) 0.439 (T)
Total cholesterol (mg/dL)
Initial 186.68 (37.39) 193.59 (36.43) 0.149 (T)
Follow-up 182.68 (36.60) 191.20 (40.81)
Change –1.91 (14.71) 0.250 (P) –0.06 (14.58) 0.866 (S) 0.710 (W)
HDL cholesterol (mg/dL)
Initial 49.63 (21.87) 42.84 (21.56) 0.398 (T)
Follow-up 48.36 (49.34) 46.46 (49.83)
Change –38.77 (169.59) 0.027 (S) –4.82 (137.88) 0.475 (S) 0.438 (W)
LDL cholesterol (mg/dL)
Initial 112.10 (34.53) 119.55 (32.50) 0.152 (T)
Follow-up 110.37 (34.39) 113.13 (31.26)
Change 0.75 (28.06) 0.823 (S) –1.87 (17.30) 0.147 (S) 0.497 (W)
Triglycerides (mg/dL)
Initial 135.47 (78.42) 128.92 (65.62) 0.697 (T)
Follow-up 153.47 (100.16) 130.13 (64.25)
Change 20.56 (63.98) 0.009 (S) 5.74 (38.00) 0.456 (S) 0.053 (W)
Hepatic steatosis index
Initial 33.94 (24.32-45.64) 32.84 (19.42-52.66) 0.050 (T)
Follow-up 34.17 (25.29-49.30) 32.88 (22.70-46.55)
Change –0.22 (9.12) 0.816 (P) 0.47 (8.25) 0.579 (P) 0.585 (T)

HPE, Helicobacter pylori (H. pylori) eradication; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PS, propensity score.

Between-group P-value: categorical data, chi-square test (C) or Fisher exact test (F); continuous data, independent t test (T) or Wilcoxon rank-sum test (W); within-group P-value, paired t test (P) or Wilcoxon signed-rank test (S). A P < 0.05 was considered statistically significant.

Data are presented as mean (SD) or median (range).
J Neurogastroenterol Motil 2023;29:352~359 https://doi.org/10.5056/jnm22179
© J Neurogastroenterol Motil